No insider purchase over the last 90 days. The latest, by MONTGOMERY ROBERT L, was filed 29 Dec 2017.
This page follows insider dealings at Reliv International Inc as filed with SEC (Form 4), a company from the Food & Beverage sector. Nothing new has been filed by managers of Reliv International Inc in twelve months, the latest record being from 29 December 2017.
Our records for Reliv International Inc go back to 2016, with 31 purchases and no sales on the open market in total.
Other companies in the same market with recent insider buying flagged by our signals: Xenon Pharmaceuticals Inc. and Applied Digital Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2019 · cache
25 of 31 declarations
Reliv International Inc is a company focused on nutrition and health, providing dietary supplement products. It is listed on NASDAQ under the ticker RLVI.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2019 | 35.1 m USD | -444,357 USD | -0.25 USD | 10-K |
| Dec 2018 | 36.1 m USD | -1.9 m USD | -1.03 USD | 10-K |
| Dec 2017 | 41.8 m USD | -696,912 USD | -0.38 USD | 10-K |
| Dec 2016 | 45.5 m USD | -625,055 USD | -0.34 USD | 10-K |
| Dec 2015 | 51.8 m USD | -1.2 m USD | -0.67 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.